Thea Sinensis 1 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02234754) held by Dolisos Canada Inc., containing Thea Sinensis. Health Canada lists its status as Cancelled Post Market (status date 01 Aug 2007). Nexara Health has matched 9 registrations of Thea Sinensis across 1 other regulated market.
Health Canada registration
| DIN | 02234754 |
|---|---|
| Brand name | Thea Sinensis |
| Active ingredient | Thea Sinensis |
| Strength | 1 X |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 01 Aug 2007 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Thea Sinensis registered in other markets
9 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Thea Sinensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Thea Sinensis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Thea Sinensis (DIN 02234754) marketed in Canada?
No. Health Canada lists DIN 02234754 as Cancelled Post Market as of 01 Aug 2007.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Thea Sinensis registered outside Canada?
Yes — Nexara Health has matched 9 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02234754, status date 2007-08-01; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02234754, status date 2007-08-01; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02234754, status date 2007-08-01; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.